Header cover image

Spanish (IBEX) Clinical Research and Equipment Industry Analysis

UpdatedJan 03, 2025
DataAggregated Company Financials
Companies1
  • 7D3.5%
  • 3M-1.7%
  • 1Y-6.8%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 3.5%, with all of the companies up. In the past year, the industry is down 4.8%. As for the next few years, earnings are expected to grow by 89% per annum.

Industry Valuation and Performance

Has the Spanish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Jan 2025€60.8m€14.4m-€5,315,756.00n/a-11.4x4.2x
Sun, 01 Dec 2024€61.5m€14.4m-€5,315,756.00n/a-11.6x4.3x
Tue, 29 Oct 2024€61.0m€10.0m-€4,656,398.00n/a-13.1x6.1x
Thu, 26 Sep 2024€61.0m€10.0m-€4,656,398.00n/a-13.1x6.1x
Sat, 24 Aug 2024€54.0m€10.0m-€4,656,398.00n/a-11.6x5.4x
Mon, 22 Jul 2024€53.4m€10.0m-€4,656,398.00n/a-11.5x5.4x
Wed, 19 Jun 2024€53.4m€10.0m-€4,656,398.00n/a-11.5x5.4x
Fri, 17 May 2024€54.2m€10.0m-€4,656,398.00n/a-11.6x5.4x
Sun, 14 Apr 2024€54.8m€6.8m-€2,704,349.00n/a-20.3x8.1x
Tue, 12 Mar 2024€54.8m€6.8m-€2,704,349.00n/a-20.3x8.1x
Thu, 08 Feb 2024€57.3m€10.6m-€3,841,297.00n/a-14.9x5.4x
Sat, 06 Jan 2024€59.6m€10.6m-€3,841,297.00n/a-15.5x5.6x
Mon, 04 Dec 2023€58.4m€10.6m-€3,841,297.00n/a-15.2x5.5x
Wed, 01 Nov 2023€66.4m€10.5m-€3,849,077.00n/a-17.2x6.3x
Fri, 29 Sep 2023€69.4m€10.5m-€3,849,077.00n/a-18x6.6x
Sun, 27 Aug 2023€73.4m€10.5m-€3,849,077.00n/a-19.1x7x
Tue, 25 Jul 2023€69.2m€10.5m-€3,849,077.00n/a-18x6.6x
Thu, 22 Jun 2023€68.0m€10.5m-€3,849,077.00n/a-17.7x6.5x
Sat, 20 May 2023€67.1m€10.5m-€1,847,355.00n/a-36.3x6.4x
Mon, 17 Apr 2023€60.4m€10.5m-€1,847,355.00n/a-32.7x5.8x
Wed, 15 Mar 2023€57.3m€10.5m-€1,847,355.00n/a-31x5.5x
Fri, 10 Feb 2023€62.3m€10.5m-€1,847,355.00n/a-33.7x5.9x
Sun, 08 Jan 2023€57.0m€10.5m-€1,847,355.00n/a-30.9x5.4x
Tue, 06 Dec 2022€51.9m€10.6m-€825,345.00n/a-62.9x4.9x
Thu, 03 Nov 2022€51.5m€10.0m-€1,031,014.00n/a-49.9x5.2x
Sat, 01 Oct 2022€46.8m€10.0m-€1,031,014.00n/a-45.4x4.7x
Mon, 29 Aug 2022€50.6m€10.0m-€1,031,014.00n/a-49x5.1x
Wed, 27 Jul 2022€50.6m€10.0m-€1,031,014.00n/a-49.1x5.1x
Fri, 24 Jun 2022€42.6m€9.8m-€1,522,537.00n/a-28x4.4x
Sun, 22 May 2022€45.6m€9.8m-€1,522,537.00n/a-29.9x4.7x
Tue, 19 Apr 2022€46.3m€9.8m-€1,522,537.00n/a-30.4x4.7x
Thu, 17 Mar 2022€44.8m€9.8m-€1,522,537.00n/a-29.4x4.6x
Sat, 12 Feb 2022€40.8m€9.8m-€1,522,537.00n/a-26.8x4.2x
Mon, 10 Jan 2022€44.1m€9.8m-€1,522,537.00n/a-28.9x4.5x
Price to Earnings Ratio

-28.9x


Total Market Cap: €44.1mTotal Earnings: -€1,522,537.00Total Revenue: €9.8mTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Clinical Research and Equipment Industry Price to Earnings3Y Average -25.7x202320242025
Current Industry PE
    There is only one company in the Spanish Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 14% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Spanish Clinical Research and Equipment compare with similar industries?

ES Market1.79%
Healthcare2.33%
Life Sciences3.51%
Clinical Research and Equipment3.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PANG Pangaea Oncology€1.773.5%
+€2.1m
-6.8%PS4.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PANG

€1.77

Pangaea Oncology

7D

3.5%

1Y

-6.8%